Literature DB >> 18375969

MICs and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii.

Josep M Torres-Rodríguez, Eidi Alvarado-Ramírez, Francisca Murciano, Maite Sellart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18375969     DOI： 10.1093/jac/dkn132

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  9 in total

1.  Effects of Pimenta pseudocaryophyllus (Gomes) L. R. Landrum, on melanized and non-melanized Cryptococcus neoformans.

Authors:  Orionalda de Fátima Lisboa Fernandes; Carolina Rodrigues Costa; Ruy de Souza Lino Junior; Marina Clare Vinaud; Lúcia Kioko Hasimoto E Souza; Joelma Abadia Marciano de Paula; Maria do Rosário Rodrigues Silva
Journal:  Mycopathologia       Date:  2012-08-30       Impact factor: 2.574

Review 2.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 3.  Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals.

Authors:  Edmond J Byrnes; Karen H Bartlett; John R Perfect; Joseph Heitman
Journal:  Microbes Infect       Date:  2011-06-01       Impact factor: 2.700

4.  A Fatal Fungal Infection: Cryptococcus gattii (VGI) Meningitis in Texas.

Authors:  Marisa C Nielsen; Joshua M Peterson; Billie Shine; J Patrik Hornak; Aimalohi Esechie; Sandeep Bhatt; Kinjal Desai; Alok Dabi; Michelle M Felicella; Ping Ren
Journal:  Open Forum Infect Dis       Date:  2022-05-09       Impact factor: 4.423

5.  Fluconazole Susceptibility in Cryptococcus gattii Is Dependent on the ABC Transporter Pdr11.

Authors:  Mai Lee Yang; John Uhrig; Kiem Vu; Anil Singapuri; Michael Dennis; Angie Gelli; George R Thompson
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

6.  Azole resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the role of ERG11.

Authors:  Charles E Gast; Luiz R Basso; Igor Bruzual; Brian Wong
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

7.  Microbiological characteristics of clinical isolates of Cryptococcus spp. in Bahia, Brazil: molecular types and antifungal susceptibilities.

Authors:  C S Matos; A de Souza Andrade; N S Oliveira; T F Barros
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-26       Impact factor: 3.267

Review 8.  Central Nervous System Cryptococcal Infections in Non-HIV Infected Patients.

Authors:  Justin Beardsley; Tania C Sorrell; Sharon C-A Chen
Journal:  J Fungi (Basel)       Date:  2019-08-02

9.  Clinical and microbiological characteristics of Cryptococcus gattii isolated from 7 hospitals in China.

Authors:  Liang Jin; Jing-Rong Cao; Xin-Ying Xue; Hua Wu; Li-Feng Wang; Ling Guo; Ding-Xia Shen
Journal:  BMC Microbiol       Date:  2020-03-30       Impact factor: 3.605
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.